NEW YORK (GenomeWeb News) – Beckman Coulter today said it will buy the flow cytometry business of Dako for an undisclosed sum.
 
Included in the acquisition are Dako’s MoFlo XDP cell sorter and the CyAn research flow cytometer.
 
Beckman President and CEO Scott Garrett said the addition of these tools and assets to its flow cytometry line allows it to offer “a more comprehensive range of research solutions to our customers.”
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.